Lamotrigin 1a Pharma (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which reduces the excessive firing of nerve cells and limits the release of excitatory neurotransmitters such as glutamate. This action helps to prevent seizure activity and contributes to mood stabilization.

The appropriate dose of lamotrigine is individualized by the prescribing clinician based on the patient’s age, indication, concomitant medications, and renal or hepatic function. Dosage titration is typically gradual to minimise the risk of skin reactions.

Safety data for lamotrigine in pregnancy and lactation are limited. Clinicians weigh the benefits of seizure control or mood stabilization against potential risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To request Lamotrigin 1a Pharma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamotrigine offers a broad spectrum of activity against both focal and generalized seizures and has mood‑stabilizing properties, which distinguishes it from many other antiepileptics that lack psychiatric benefits. Its side‑effect profile is generally favorable, though clinicians monitor for skin reactions more closely than with some alternatives.

Lamotrigin 1a Pharma should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Do not store in a bathroom or near heat sources, and keep out of reach of children.

Lamotrigin 1a Pharma is taken orally, usually as a tablet, with or without food. The exact dosing schedule, including the need for titration, is determined by the prescribing physician based on the individual’s therapeutic needs.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, as well as rare blood disorders like aplastic anemia. Prompt medical attention is required if a rash or signs of infection develop.

Lamotrigine is contraindicated in individuals with a known hypersensitivity to the drug or any of its components. Caution is also advised for patients with a history of severe skin reactions, significant hepatic impairment, or those taking interacting enzyme‑inducing medications without proper dose adjustment.